V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209204 | 20167646 | 1.63 | 71.5 | null | 2016-10-13 | 2017-11-17 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101225679 |
| 20209213 | 20167647 | 1.77 | 119.1 | Palliative (P) | 2020-02-06 | 2020-02-06 | Cetuximab 14 day | N | N | CETUXIMAB | 101411465 |
| 20209218 | 20167648 | 1.87 | 69.1 | Palliative (P) | 2019-06-16 | 2022-04-18 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 101611987 |
| 20209237 | 20167649 | 1.73 | 68.2 | Neo-adjuvant (N) | null | 2021-01-05 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101172451 |
| 20209249 | 20167650 | 1.7 | 66.1 | Neo-adjuvant (N) | 2021-05-29 | 2021-07-10 | Trastuzumab | 02 | N | TRASTUZUMAB | 100644292 |
| 20209312 | 20167651 | 1.76 | 50 | Palliative (P) | 2020-01-15 | 2020-01-22 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100393692 |
| 20209323 | 20167652 | 1.85 | 64.1 | null | 2021-08-08 | 2021-08-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101524834 |
| 20209349 | 20167653 | 1.92 | 67.2 | Curative (C) | 2019-06-05 | 2020-03-15 | Trastuzumab | N | N | TRASTUZUMAB | 101420227 |
| 20209473 | 20167654 | 1.73 | 68.6 | Curative (C) | 2022-01-17 | 2022-02-02 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100036114 |
| 20209491 | 20167655 | 1.64 | 120 | Palliative (P) | 2014-09-30 | 2016-04-12 | Trastuzumab | 02 | N | TRASTUZUMAB | 100823261 |
| 20209494 | 20167656 | 1.73 | 84.5 | Curative (C) | 2017-03-15 | 2017-03-15 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101656465 |
| 20209549 | 20167657 | 1.62 | 71 | Adjuvant (A) | 2019-12-09 | 2020-01-04 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101688674 |
| 20209558 | 20167658 | 1.81 | 77.9 | null | 2020-01-31 | 2020-02-21 | Cetuximab 14 day | 02 | null | TRASTUZUMAB | 100910086 |
| 20209704 | 20167659 | 1.81 | 83.5 | Palliative (P) | 2020-02-23 | 2020-02-24 | Trastuzumab | 02 | N | TRASTUZUMAB | 101729886 |
| 20209705 | 20167660 | 1.58 | 62.6 | null | 2019-08-26 | 2019-08-26 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101417591 |
| 20209738 | 20167661 | 1.75 | 108 | null | 2018-02-23 | 2018-03-08 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100520149 |
| 20209775 | 20167662 | 1.87 | 92 | null | 2018-08-07 | 2018-08-26 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101634766 |
| 20209794 | 20167663 | null | null | null | 2017-01-27 | 2017-09-25 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101380848 |
| 20209798 | 20167664 | 1.64 | 66.6 | Curative (C) | 2021-05-25 | 2021-09-03 | TRASTUZUMAB | 02 | Y | TRASTUZUMAB | 101849799 |
| 20209820 | 20167665 | 1.73 | 56.6 | Palliative (P) | 2017-10-09 | 2017-11-23 | Trastuzumab | 02 | N | TRASTUZUMAB | 101482780 |
| 20209831 | 20167666 | 1.76 | 63 | null | 2021-04-18 | 2021-05-01 | Trastuzumab | 02 | null | TRASTUZUMAB | 100702545 |
| 20209840 | 20167667 | 1.8 | 48.5 | Curative (C) | 2017-08-24 | 2017-08-25 | Trastuzumab | 02 | Y | TRASTUZUMAB | 100975261 |
| 20209843 | 20167668 | 1.74 | 80.4 | null | 2017-04-14 | 2017-05-06 | Capecitabine + Cisplatin | N | null | CAPECITABINE + CISPLATIN | 101139270 |
| 20209902 | 20167669 | 1.87 | 63.1 | null | null | 2020-01-14 | CETUXIMAB | null | null | TRASTUZUMAB | 100492349 |
| 20209907 | 20167670 | 1.66 | 46.6 | Palliative (P) | 2018-03-19 | 2018-03-23 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101787960 |
| 20209917 | 20167671 | 1.73 | 61 | Palliative (P) | 2020-03-05 | 2020-06-13 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100547280 |
| 20209928 | 20167672 | 1.71 | 76 | null | 2017-10-15 | 2017-11-09 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100982535 |
| 20209950 | 20167673 | 1.66 | 105.8 | Palliative (P) | 2019-10-26 | 2019-12-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 101468199 |
| 20209983 | 20167674 | 1.75 | 56.6 | null | 2020-04-04 | 2020-04-04 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100007128 |
| 20210021 | 20167675 | 1.55 | 92.5 | null | 2018-11-29 | 2018-12-14 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100964593 |
| 20210024 | 20167676 | 1.64 | 65 | Adjuvant (A) | 2019-07-24 | 2020-04-17 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101677655 |
| 20210029 | 20167677 | 1.59 | 66.1 | null | 2019-07-15 | 2019-07-16 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101636630 |
| 20210078 | 20167678 | 1.74 | 90.85 | Palliative (P) | 2021-07-13 | 2021-07-13 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100725976 |
| 20210113 | 20167679 | 1.66 | 69.1 | null | 2018-10-24 | 2019-08-11 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101820538 |
| 20210114 | 20167680 | 1.64 | 79.8 | Palliative (P) | 2018-09-11 | 2018-12-26 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101173437 |
| 20210151 | 20167681 | 1.58 | 75 | Palliative (P) | 2019-06-01 | 2019-06-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101712713 |
| 20210216 | 20167682 | 1.72 | 102 | null | 2022-03-30 | 2022-03-30 | Cetuximab 14 day | N | null | CETUXIMAB | 100163435 |
| 20210235 | 20167683 | 1.63 | 43.1 | Palliative (P) | 2020-09-12 | 2020-12-06 | Capecitabine + Cisplatin | null | N | CAPECITABINE + CISPLATIN | 100368579 |
| 20210238 | 20167684 | 1.82 | 62.6 | null | 2019-04-26 | 2019-05-19 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100660603 |
| 20210268 | 20167685 | 1.7 | 80.6 | Palliative (P) | 2020-09-07 | 2020-11-13 | Trastuzumab | 02 | N | TRASTUZUMAB | 100547071 |
| 20210272 | 20167686 | 1.82 | 81.35 | null | 2016-05-24 | 2017-12-10 | TRASTUZUMAB | 02 | null | CETUXIMAB | 100620408 |
| 20210285 | 20167687 | 1.62 | 92 | Palliative (P) | 2017-11-20 | 2018-01-09 | CETUXIMAB | null | N | CETUXIMAB | 100822570 |
| 20210309 | 20167688 | 1.87 | 79.6 | null | 2018-09-22 | 2019-02-02 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100481890 |
| 20210326 | 20167689 | 1.82 | 73.3 | Palliative (P) | null | 2020-02-23 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100037464 |
| 20210348 | 20167690 | 1.73 | 106 | null | 2017-08-03 | 2017-08-04 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 101018403 |
| 20210371 | 20167691 | 1.62 | 72.7 | Palliative (P) | 2016-09-08 | 2019-08-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 100043404 |
| 20210398 | 20167692 | 1.65 | 83.8 | Curative (C) | 2020-08-17 | 2021-02-08 | Trastuzumab | 02 | null | TRASTUZUMAB | 100148336 |
| 20210431 | 20167693 | 1.83 | 66 | Adjuvant (A) | 2020-11-21 | 2020-11-25 | TRASTUZUMAB | 02 | Y | TRASTUZUMAB | 100019435 |
| 20210463 | 20167694 | 1.87 | 56.3 | null | 2022-01-01 | 2022-04-08 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101182649 |
| 20210466 | 20167695 | 1.65 | 69.7 | Palliative (P) | 2020-07-20 | 2021-06-15 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101622541 |